Verition Fund Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $1.65M | Sell |
|
|||||
|
2025
Q1 | $2.42M | Buy |
|
|||||
|
2024
Q4 | $1.61M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $364K | Buy |
|
|||||
|
2023
Q1 | $241K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $238K | Sell |
|
|||||
|
2022
Q1 | $2.69M | Sell |
|
|||||
|
2021
Q4 | $4M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.23M | Buy |
|
|||||
|
2021
Q1 | $605K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $3.23M | Buy |
|
|||||
|
2020
Q1 | $1.11M | Buy |
|
|||||
|
2019
Q4 | $701K | Buy |
|